title: Board Review Vignette: Irritable Bowel Syndrome.
authors.affiliation: University of Newcastle, New South Wales, Australia.|Gastroenterology and Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Talley
mesh_terms: D015746:Abdominal Pain / Q000188:drug therapy* / Q000209:etiology; D000328:Adult; D000837:Anion Exchange Resins / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use; D002243:Carbolines / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003248:Constipation / Q000188:drug therapy* / Q000209:etiology; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D019468:Disease Management; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D000074268:Guanylyl Cyclase C Agonists / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D043183:Irritable Bowel Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D054368:Laxatives / Q000627:therapeutic use; D008139:Loperamide / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019936:Probiotics / Q000627:therapeutic use; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
chemical_list: D000837:Anion Exchange Resins; D000930:Antidiarrheals; D002243:Carbolines; D002792:Cholestyramine Resin; D005765:Gastrointestinal Agents; D000074268:Guanylyl Cyclase C Agonists; D007093:Imidazoles; D054368:Laxatives; D008139:Loperamide; D010455:Peptides; D010649:Phenylalanine; D012294:Rifamycins; D000078262:Rifaximin; D017367:Selective Serotonin Reuptake Inhibitors; C090840:alosetron; C583636:eluxadoline; C523483:linaclotide